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Abstract We report a new mutation in the sterol 27"hy­
droxylase (CYP 27) gene in a Dutch family with cerebro­
tendinous xanthomatosis: a G~^A transition in the splice 
donor site in intron 4. This mutation leads to skipping o f 
exon 4, resulting in a loss of 66 amino acids in the CYP 
27 enzym e molecule.
Introduction
Cerebrotendinous xanthomatosis (CTX) is a rare autoso­
mal recessive lipid storage disease characterised by a dis­
turbed bile acid m etabolism  caused by a deficiency of the 
mitochondrial enzyme» sterol 27-hydroxylase (CYP 27), 
Deficiency of this enzym e leads, among other things, to 
an excessive production of cholestanoi that accumulates 
in many tissues (Björkhem and Boberg 1995). The clini­
cal spectrum of CTX is characterised by premature bilat­
eral cataract, follow ed by neurological and neuropsychi­
atric abnormalities and formation of tendon xanthomas
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(Bjôrkhem and Boberg 1995). In children, the combina­
tion of bilateral cataract and intractable diarrhoea is in­
dicative of CTX (Cruysberg et al. 1991).
The cDNA which encodes the rabbit mitochondrial 
CYP 27, a member of the mitochondrial cytochrome P450 
enzyme family, was elucidated by Andersson et al. 1989. 
The cDNA of the human CYP 27 has been cloned and its 
gene localised on chromosome 2 (q33-qter) (Cali and 
Russell 1991). The structure of the human CYP 27 gene 
was elucidated by Leitersdorf et al. (1993).
In the Netherlands, 39 CTX patients from 18 families 
have been identified up to the present. This report de­
scribes a new splice site mutation in the CYP 27 gene in 
the Dutch CTX population, a mutation which was found 
in three patients from one family.
Materials and methods
Subjects
The clinical and biochemical characteristics of the patients (from 
non-consanguineous parents) are described in Table 1. The di(Ter­
ence in phenotypic expression between the three siblings is re­
markable. An intractable diarrhoea, a symptom rarely reported in 
adult CTX patients, was present in patient A. Clinical signs and 
symptoms were most severe in patient B: she had severe Parkin­
sonism, a syndrome that has been previously reported in CTX pa­
tients (Rogelet et al. 1992; Shibata et al. 1990). The frequently de­
scribed cerebellar signs were absent in patient C.
Biochemical analysis
The cholestanoi and cholesterol levels in serum and the urinary ex­
cretion of bile alcohols were measured according to Wolthers et al. 
(1983, 1991) using capillary gas chromatography.
Mutation detection and restriction analysis
The CYP 27 gene was amplified in four fragments (exons 1, 2, ex­
ons 3-5 and exons 6-9), by PCR from genomic DNA of leuco­
cytes. Exons 3-9  with their intron boundaries were subsequently 
amplified separately, with the two PCR fragments 3-5 and 6-9  as 
templates (Luyten et al. 1995). The oligonucleotides used as
& r-
f .
T O , - v , ; .
•" ^ - V i v - Æ
v;.v-'^TT,v*
v : ^ -
, \
' ^ ' x é
s .l\ -V w*
■ % #  
; # < Ä  
•>





^ Y ï ï R
'&<■&?.
“T : ■
? $  V 
:•?. 
¿ v■ '  'C? *1
-7
.>!■;■...........Cv-
Â îî' w w ÆÎ.
¿L
': ? ,v .- ¿ > '
V*" ^
I '  'h
'.v.' 









rV í¿ V > ^ -
ÿ “ --:. í ;  .
% S U :
¿ ß - > :
*. L.
3 . ' ' '
-<2  v
m . :i
v f - r S y■■ v> \ i \  ■
^  . .
M -  %
¿r::_w-: ^ rc- 
, | l
. ' ö ,




F i p S - t t i v .
• # % .
' ■ ' Ä ?
••- -Ii'  1; -   ^■
■ ^ ^ 0'
. # %
#
"* ■ j '
/ ^ ? .
." ■ ■ 
.Y.'.'
. . . . .  ■..Vs1 
• • ••• •;;. 
^ ■ r- #
i
•>-; J:'? ." '
'  ' '<■■ ' - ; .
%  - * >
c ; .; :* .\y .w ;:.$ ,
..■.■.■........ . ... -s.
J & & r i .
W -  ' ' ÿ
■- i ■.'--•
¿ V V , . .
M . 'Z'.
x - ^ - %
•> ■
.■•’>•■ ■>






ü i-> — A'J
••••ä  • ; 
s'■ :'*
•••
■ V ■ ■£$>,■ 
?•:
| & * > S r
^  ' è  .-.' ••■ •¿y -±<.
'.►•.*1
. ÿ i i - v Â
1 ^ :




' ' • 7 v í í ? ? '











^  ' I
t J
•.ÍS ''







' Ä - . . .
v. ■ ■
y * ........v
> 7 ~ _ 5 ÿ ÿ
¿ i  
;-í> .v ;
- Ä ^ :
! 0 ^ h ,
ß :  " %  
^ m 0
i - ? :V = ^ 4
............
§ Â Æ r - ; i  
• /
- Ï K c S - ÿ - '
■ 'k ï “ ^ '
ÿ :











■- ^  
•. $  %  .  . . .  ^
' • ■¡Vk O 't
■ -¿7 '.•■
.-  # V-
•"-'>"• ....
Va
% Z $ £ é i-
■ • ■ • *“ X
'V- • T- i l '  
''•■•I'"









. ;  ■ ■ ■.’v '  : ”. ;




s ■. . . . . .  \
r ' A .%# J
" ” x
- Â -V- " :-sV
•/ -.-' ■:'■ i." . -:ôÿ^-




s :  
- • ¿ .i . .
'■‘v'C-
¿ r




> ;-c v  
f
• • • - . ; $
V ;."
' A ' t ë s ’Z y/Ö .
^ • í w S ¿ ;
S.1" . 1. .
• r
fS :  




X e ^ • • '
# "I
i, :i 
>'•>1 \ ,.,.,.,;>-, ,
€JV 1'.
.*>■ ■
■ *. 1 . v 
i .
% : '" . . . .
r
-
•.:î ?  ,■V ■ ■ - T.






5 r Ä ^





'-y -.-- . ',- :"
f S î :
..%i;;y...: '.~ -.'— r.~.-'m.
^ # " : 
^ ÄjssS






■ ïY ,é}sïX 0
>: ' - ï à  
< & m £
•v::ÿ- . J  
'---ic< --'-
#%
. . í v ! 1







.r’' -  :v- %# 
Q
• Ä f :
' * ï ^ S v < ï ^
*■1 ■ j''*
'';^ s # :'
•= tó = í? .




- v ^ ï Â Ài  '■■'
-r.'.;.’i'7'-
'....'■
• l,1-*-' M ■-—'
ír-.vr-;'--?:.
? á '  ^  
^ ¿ 7; -
V - : i . , v
ÒV
-r-.-ïir<îiv
,£^ Í 0 :
;^. f
' W k'íV ^ x
-•.'; y f í- :^ - :-^ .
•■»' • .V.
v " : '  i ;




< í r *^%.
O- •■
:-" 'JV 'T i..
'•





â  ì .' . - . . ,Æ
••••rt-W
• . ' i .. * . . .
•- * * =■■ .. ■S*i‘ ■''
Ì -
í :--
: :¿ f f
^  :-
:^ 0 y $




■ : ÿ ; .
Ä
I
m i m i
. . .  . . .  -v..
r ^ v ^ r *
■;:; '.v'.. ' i
■y- V-S'ÿ
■■■S*1'-*.
•^îrCS. é : -
■ '••• ''■ ,,í s  ?
■ ■"■■■ \ ' ï
i ' i




' % ; ö r - '
^cçcKrlfe'?^
'




*. V . . . . . .
v*Ö f-




¿SS í Íí^ í
« f
. Ä ,
¿ fS W 'S â .
V ' ■
\■;SÍ?.'■ ■ J ?'■ ■
N. ■:'•V. Ä'Vil
' ■ *.. 
■ ' ^ #  




-•  . # • - .
















! v r M -•:r>- v
•7v ^ L ~ : ^
‘ v  , % \ v  ■ ■ . . . . . . _ . .
f
« t fy>\~:
• " ' - v
s i s s t .
= s r  1 ^ 5 ? . .
^ 4 , ,
.—v“ " ■—. . ■'.—V;.... :v. 
X : ^ _  
/ f -  W ¿ %
I ’ 5 :








p .  ^ i 'i;# ; 'î i : ;
• V.1.’-. --W
■ w 1
t #Ñ ^ ' .%<
A  \
î ? - j ÿ c ü ^
ÿ w îi ’-'ivSL,




^ > Î T » .




j  *. * • >- V .\* .
cv





¡ v  •
wC-v v
S Â ^ :
■ p fr
%-
1 5 5 » .
•ÎtÂ IÎ’-ÎÎ.
it -








■ ::Â v  
â :
ï^ l 
f  ' . . "  


















- : ^ V
W - f
' i - . .
v
■ • ;"l . £  
■
W - i #
"■&




;¿ . :.. .. J '
• • ^  ':i  
• :¿ Æ .

















f "  ’ i, 
%  >,
*  i 
. . . - i " '
f
%v<ñ?ú.
'A - "  V' 





ÍF ,^ ^ -
f  %
S'-
v i■T, Cf :^ =ss?' ' ^ # 5'
\
' : è # ;
'■'í-^ m^ v.,-;.''








í ' . .
% '. .
jß i  \  
-  i *
$■,









. V  1 ..*.
^ s æ s a s
:£ ; -
.........* i :
f í v ¿ £ í S '
'¿H.- 
'^ S rÿ ÿ ià :
'<C:.
fg’.:.'ii:t:i:
' i  
:^ .  è
.ïrj.r£.:;:;:%.
ÿ - .




m .  i
f e
'V s ^ ^ :
p - ' -ts




. . .  ^ ^ y .
J:fe•fc*y. •• 7:.
Xv.;:;:..;ii.
W " : - è :
'M r t
V” *






«  . # r " ^  
£  ^  ■
>V ' "■:■>'■
| i s « 4
.• ; :^ :r¿?s
#
-¥.■ ■.■■■•.
I  I  
->;í #
i










• % ^ r '
fs y & W g ;
\: ,- . . . .  : è -  
' ,y .w ? * '
è ^ ÿ - '( t c i
M :  t
m










■ •■ ¿ í ‘K  











r' ^ & r ’
/ S y | .
• v ^  ,.u-
éj
. 1
~ < -ì£ p
¿ < - M .
'-¿F' ■
Â: *' 
p.. -^ -r-:- tv ^
' •••:*' >• V\ .
•>P-
*¿ . . .1 •. !• •
% $ ê ' - t 1 ■








% k - . .
i -
' ^ '  
m
>sÆ “"





i '  ■*. 
■*-’
g
. ^ - 3 V -
•S.








r . . , . .
•Wb
0 t m $
f e : p :
;- ; - g  . ' :i
' :v lä -
- '^ : : : - : 4 v  
#  "
f , . ..... ..
¥ ;•  '-*■■
>'•
I I ,
i t ç té k ç s z ïé .  
¿W
■ p s m g ig & . &
M -
% m ïm  
h ' ' ' '  '
# ^ 1 '
£<. i
:';.-.-:i.-.-- M ' 
W. "
i;#i 
'T i '  *** .*.V'/'






%■■ W M fik :







.« :-  Ä .
t :
■>f.-V..” .l»
v . .  . ...••■
$ .  ^ î ? s | |
, ^ S 9 = f





í ’-"'” ' ""í>.
¿ Í í ^ í í f l '  
% %
'. - - . v - . , .
P ^ t
M
- S - .

















■ *  %
i ’i : ^  







:^ . :?■' 
v = ^ s ^ - '
M .
fu-
^ S ? S $
f ,  ¿




m .  . j ?
^ í t v í ^ '
r # ^
^ • : - ^
s s * ?
*<*.
7 & É i
i í # -
^ , 4 -
vCT<>a^l\>W'
Í 5 5 -
ÏV-.
Ä '  ' 4^  . -TVSv
í ? '  • *
gs 3  . _
•■¿••s..__ . a»
P : .^ h  




C V '- '- '- "
1 ? ^ . . 5 = >
%  % í í '
0 '
f "  
#;Í
5 - . .  f t
*  . . a .




V 7 ■’'  ■ Ä \




íf ."  í :  ¡"  ' ^
%  _ í ;
■ ^ , ■ S l S ÿ ^ :
ív .





g i g 0 é .
^ s .. - v_
• i ^
:« v S W d

















. « s s  
f e  Â-
*














- ^ . ;
V.













: • .■ ■ *s ■. ■ ■ -ÿ
m .  :%■
' ■ i Æ ^ '
.'.v-'.v:
^ = r-- - .
i v '
I  ..................
... . —/ . f  w - ' :
S^' 1 1 y/ v^ ö^S.' 
0 . 0 Ì
" : ■••;■ : ■> 
!.':1 '-i'iv'





,*s' ■ ’.v : . 
r % ? . #  '
, .  m .
p ¿ v ? : S ^
. 0 -  \ .  í>\-, ry.
I
M ,  %
r ^ ! #  
» > i  ' s .
"»
■ ¡ :  . ^







¿ ¿ v ? ? ;








^ ■ ■ ■ ^  
.^ v ^ v iíí 
■■ ■■ 




■'\. . . ^,
0%
.•iÄv-:^:
,  ■. ■ ■ ^ . ■ ■ ■ <■
'•••Î-: "¿i*- 
 ^ I
■ ■ .'Jj 
,-ííí<‘í<«í 
■■;■■■ v¿-:-^ 






. - v ^ í v i y
£•
ié íS jK íS '
■v.. ;>■.
• ? £ ^ '; .S :
1
H  i m \







■ ■ •> '  ■ ... s :
'ÍS ’?' . -S>
è ^ . v :ÿ ; .
9?
.v . ■ ■ ■?,'■, - ^ . . . . s.-.‘
• i i ?  Vii-
5 i i S ^ .
"  Æ. ...
#J . .  ¿ í  -  •
5;.
 ^" \  
f% *  
. ^ ^ » V
v r # '
2?







.• '. ^ - - v .
•_■ .i
W ^ j Î :
■ r  " i
M  "¿ .
s . S- 
- ^ i2 ^ ........... ÿ : 1 ■ ■ v ■ v
■ * 0 ïë . | f - 3 ?
' í s
r?’. : ^ * : É .  % .
■:«?■ \ î  s
' V « P •-Í'-
•<ViV'-
■i'. í v ^ í í ^ !  
• .  !
S' '
Û 'r ÿ ^ : -
^ . . . .
.Æ î j r ^ lS '
■2i.
W :'- $
0 -  \ X: ï;
^ . ._
c-- :x. .* . W
“k .
'  .  »
^ s v - M i ä
iP& zf
f : ; . ' : . .  Ä -
. f ÿ 5 - Â ^
t ¡  ■
^ - r - í ?  
SEr S f ' ^ í ü
::^ y !
5  £  
‘Z - l ÿ à t e æ S '
:^ 5
?
■ & & y r ¿
"O ' r*r'
i r  ,,
'  • ä -  ;
. s
§








V - è ; . . , #
- T -
’s f x
\ - M  : '<&■




. -  -• 
- .  v
..•>
?
W i i ' ï .  






£ fS Ç P &
^ c r r i ÿ i
f  ' *
#5ÍÍÜ?S
u - -i 
?  i '  
' ^ ÿ s -
~  5 ^ Â - V ^ i -
i  Ì  
¿ ■ ÿ - & ;
. f i ? .  -v  
' i ' '  f
Î S r ï S ^ S Â  




V - v i - ~
, ; - ï
> .
' % N # *
■i1
•ta.
-J L |rv :-L ;£ ? '’
S í ^ S s v S S :
' " > J
S :
•:*  • '■ '.;•#
. A
_<ï-
*  ^ 7 ^ .  
■ - - Í
i>  s ? ? ÿ ï ^ :  
i*4




. • . ■ s s ^ ÿ i
^ S ^ K S ^ î .
f X
- y
_ Æ S j ÿ » § ;
• ¿ • ’" V i ê .
Æ v
i , , .




^ V  
ÍS'. Í:
• t -
0 > ï r ÿ
^ ■ V ' w ÿ
S - Â ^ i - i Ï T
"f.’
“ ■
■■ ^  ■■:
^§5SS.
■ • S'^  V
| :  s
S ? r = ï- &
%
,'f & & & §
, p r 7 Â - ^ i j
« :  ■
'
4 ;K ‘;r¿ V .! - - > í
«s
■ $ ? ? ; * ? $
■ ^ *.■ ■ . c 
• f e ” - : ; #
• ■ • ^ '  - Ä  
Ä: £‘S5S£:
#  I  
s




m -  A
* \ . ;-.#ï 
/-^ .. V,
•ÿ:Æ J






v / , . .
^ Ç p '
J &
-r- jg^z






“ •V W :
^ i S $ T 3 |
, ÿ  ^
W
i- * ‘T.
- ,  ■!






■ &  " i . 
f t  Í,', 









^  S  J '
‘iï 'i#
î ^ :
%  : % | f  
| | .  t  
f " ' | :'









s** *,. * ,¿ 
•s-
--
Ì & .À'"vS^ V
6<1'
w  Lf  l :
Ö , j - ,  ••s *.
^ ß %  
-?0 :sÿ
i ë -
/ - : v ,
:*Ss«
















V.'. oSs: '.;v 
*  * .



























'y / \ -
H.
C~'
^ # : J
s
«Î*=?S^ K:*. • f
¿¿asî^
•T*... v . \  -i>, 
\
«s
j & % £ [
^Í$0Í§.¿
f%
î \  y. 
&"
¡5Srf¿á?/




: m m ,  
^ Î û | 
^  ■%
‘è  s?P<ó5;































:# - i '
S ^ iíSzé.

























%>_ à  %*&?
>■&$
íks^ íí-




i r 4  
it
4





























f  5  
























ü s m ^ à .
í'^-S:■.:■■ ■> 
■’« •  *:
« S f .
T-
| H : f i
■V^v
^ k - .
% # 4 #
•fc s s s f t s i .












S- i ‘ 
•%. «












^ - f ' \
^  -S
^ssscà ^ ^ ■ v 4
4' 'SŸ^SiÇ
' ^
S- • • ^



















| | | | f l ! i : ;  
V-; '::i?ír.,C^.-;;--.r ':-■••:■•-•:•:•' -■:•:••:-
V :.' <J A '- / . ' ' -  - .  ! : v  • '. * '. : '  ■:: . '.'.'
s'v'-V-vrX'Ci'v;
•• • ' '  -'-■' ' V.’C. •■- —: > : '■ -.-•
W :t§ ;r" ':"':" ':'':"':-x\ ■< —',--r>;:;v- ' ■
: •iyir'
•/.•... ¿s':'<•::• -v ''-'-s'.'/** *.\**<\ : *.“sV *s ■/■•■‘.y *■■''. y-
- .; ■ * ■ •.'. \ ; ■• ■ - ‘ \ ;■.*•! ! — \ ‘ i '/■; V ■'.'■. V. '
x\:-•/;..-iy;\y,y: -"■. 
’•: -T '■■' s' ;.;.
» ••- .-:- .v''-\ - .’. :••.". ■.■■•\\“.-..‘^  'X*. v .■•
■::.- y:'¿V:^ r(^ ;:y .
...'.‘Æ.îix¿»'..•;.
iliiiiÜI







-îi^ S S £ a è
Í.’. T-
A 4fp5=i5Â





















^  s3:5 i^ .;  
-^453?^ Ä:
%--5






í.'-f f  -,
Ä; îSrTS^












■ 4&Ï 0 -.
$ S h k » b £ -
5 : . ? -




In this study, three clinically well-characterised CTX pa­
tients from one family were investigated for mutations in 
the CYP 27 gene.
Several mutations have previously been reported in 
CTX patients. Three mutations in splice sites affecting 
normal splicing have been found (Garuti et a l  1996; Lei- 
tersdorf et al. 1993). In the present communication, we 
present a novel splice site mutation: a G—»A transition at 
cDNA position 865 + 1 (intron 4), resulting in skipping of 
exon 4. This leads to a loss of 198 bp in the mRNA and of 
66 amino acids in the enzyme molecule. The patients 
were homozygous for this mutation.
The Joss of 66 amino acids in the enzyme molecule 
must lead to a considerable deficiency in the enzyme ac­
tivity. The late onset of the disease in these patients is an 
indication that this part of the enzyme molecule is not piv­
otal for its activity. This is in accordance with the finding 
that the conserved part of the gene is located in the exon
6-  exon 8 region (Leitersdorf et al. 1993). The presence of 
this splice site mutation in the homozygous form results in 
an intrafamilial phenotypic variability (Table 1), which 
points to a contribution of other factors to the phenotypic 
expression. As the phenotype of CTX is highly variable, 
even within a family with the same mutation, it is impor­
tant to search for the relevant mutation in family members 
with atypical signs and symptoms.
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